Best Healthcare Stocks to Invest in
Healthcare Stocks: Investing in Innovation
Best Healthcare Stocks to Invest in 2025
Investing in healthcare stocks in 2025 presents a promising opportunity as the sector continues to grow due to technological advancements, an aging population, and the global demand for innovative treatments. The healthcare industry spans pharmaceuticals, biotechnology, medical devices, and insurance providers, offering diversified investment options. Here’s a ranked analysis of the best healthcare stocks for long-term growth in 2025.
1. Eli Lilly (LLY)
Market Cap: $767B | Dividend Yield: 0.67%
Why It’s a Top Pick:
Eli Lilly is a leader in diabetes and obesity treatments, with blockbuster drugs like Mounjaro and Zepbound. These medications address significant unmet medical needs, ensuring sustained revenue growth. The company’s pipeline also includes innovations in Alzheimer’s and cancer treatments, cementing its position as a biotech leader. Analysts project significant upside potential with a price target exceeding $1,050.
Key Highlights
Growth Drivers: Mounjaro and Zepbound’s expansion into additional indications.
Risks: Dependency on the success of GLP-1 therapies and regulatory challenges.
Verdict: Strong buy for long-term investors seeking innovation-driven growth.
2. Intuitive Surgical (ISRG)
Market Cap: $112B | Revenue Recurrence: 86%
Why It’s a Top Pick:
Intuitive Surgical dominates the robotic-assisted surgery market with its da Vinci Surgical System, which has been used in over 16 million procedures globally. Its consistent revenue growth is fueled by recurring income from instruments, accessories, and services. As surgical robotics adoption increases, Intuitive Surgical remains a pioneer in the field.
Key Highlights
Growth Drivers: Aging population and advancements in minimally invasive surgery.
Risks: High valuation and dependency on elective surgical procedures.
Verdict: Ideal for investors seeking exposure to cutting-edge medical technology.
3. Vertex Pharmaceuticals (VRTX)
Market Cap: $114B | Gross Margin: 86.1%
Why It’s a Top Pick:
Vertex is renowned for its transformative treatments for cystic fibrosis (CF) and groundbreaking gene-editing therapies like Casgevy. With a robust pipeline targeting diabetes, kidney disease, and acute pain, Vertex’s growth is poised to extend well into the next decade.
Key Highlights
Growth Drivers: Expansion into gene therapy and collaborations with CRISPR Therapeutics.
Risks: Pipeline dependency and competition in niche markets.
Verdict: A strong choice for biotech-focused portfolios with a tolerance for risk.
4. UnitedHealth Group (UNH)
Market Cap: $469B | Dividend Yield: 1.33%
Why It’s a Top Pick:
UnitedHealth is the largest U.S. health insurer and a leader in pharmacy benefit management (PBM) services. Its stable cash flow, expansive customer base, and integrated healthcare services make it a defensive yet growth-oriented stock.
Key Highlights
Growth Drivers: Increasing Medicare Advantage enrollment and home healthcare services.
Risks: Regulatory uncertainty and competitive pressures.
Verdict: A must-have for conservative investors seeking stability and dividends.
5. Abbott Laboratories (ABT)
Market Cap: $210B | Dividend Yield: 1.95%
Why It’s a Top Pick:
Abbott’s diversified portfolio spans diagnostics, medical devices, and nutrition. Products like the continuous glucose monitoring system Lingo and structural heart devices drive robust revenue growth.
Key Highlights
Growth Drivers: New product launches in cardiovascular and diabetes care.
Risks: Competition in diagnostics and global economic conditions.
Verdict: Solid pick for long-term investors seeking steady growth and income.
Sector Trends Supporting Growth in 2025
Weight-Loss Drugs: The growing demand for GLP-1 medications (e.g., Eli Lilly's Zepbound) is reshaping the pharmaceutical landscape.
Robotics and AI in Surgery: Companies like Intuitive Surgical are leveraging AI for precision and efficiency in surgeries.
Biotechnology Innovations: Gene-editing therapies from Vertex and others are gaining regulatory approval, addressing rare and complex conditions.
Aging Population: Healthcare spending is set to increase globally, driven by the baby boomer generation entering retirement.
Investment Tips for Healthcare Stocks
Diversify Across Sub-Sectors: Consider allocating funds to pharmaceuticals, biotech, medical devices, and insurers for balanced exposure.
Focus on Financial Strength: Evaluate cash flow, profitability, and debt levels to mitigate risks.
Monitor Regulatory Risks: Keep an eye on FDA approvals and healthcare reforms that could impact stock performance.
Roundup
Eli Lilly, Intuitive Surgical, Vertex Pharmaceuticals, UnitedHealth Group, and Abbott Laboratories are among the best healthcare stocks to invest in for 2025. Each offers a unique value proposition, whether through innovation, stable cash flow, or market dominance. By understanding sector trends and maintaining a diversified portfolio, investors can capitalize on the enduring growth of the healthcare industry.
Disclaimer: The information provided in this article is for educational purposes only and should not be considered financial or investment advice.
eToro is a multi-asset platform which offers both investing in stocks and cryptoassets, as well as trading CFDs.
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 51% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
Cryptoasset investing is highly volatile and unregulated in some EU countries. Don’t invest unless you’re prepared to lose all the money you invest. This is a high-risk investment, and you should not expect to be protected if something goes wrong. Take 2 mins to learn more. No consumer protection. Tax on profits may apply.
This communication is intended for information and educational purposes only and should not be considered investment advice or investment recommendation. Past performance is not an indication of future results.
Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.
eToro USA LLC does not offer CFDs and neither does it represent or assume any responsibility for the accuracy or completeness of the content of this publication, prepared by What is Bitcoin, as a partner, using information available and public and not specific to the eToro entityRecommended Trading Brokers and Software Reviews
